Akamis Bio

Abingdon, United Kingdom · Founded 2006 · Privately Held (backing)

Operator of a clinical-stage oncology company intended to develop cancer gene therapies. Akamis Bio is based in Abingdon, United Kingdom and was founded in 2006. Its last reported valuation was $145 million in Jan 2023. It has raised $185 million.

Last reported valuation
$145.3M
Oct 2026
Priced at
—
Total raised
$184.6M
Last round
—
No prints on record

No secondary trades in Akamis Bio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Akamis Bio with a free account
  • ·The complete investor list: 25 names
  • ·Watch Akamis Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Akamis Bio prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Akamis Bio stock.